Method for preparing heat-resisting attenuated virus live vaccine for goatpox by using BHK21-C13 passage cell
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- JINYUBAOLING BIO PHARMA CO LTD
- Publication Date
- 2017-01-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the preparation method of vaccines in the field of biomedicine, and in particular relates to a method for preparing goat pox serum-free attenuated live vaccine virus liquid with BHK21-C13 subcultured cells, and adding a heat-resistant protective agent to the product to obtain a heat-resistant type for veterinary use Goat pox attenuated live vaccine method. Background technique
[0002] Goat pox is a highly contagious disease of goats caused by goat pox virus (GPV). Sick sheep manifested as elevated body temperature, papules or nodules, blisters, visceral pox lesions on the skin and mucous membranes of hairless or less hairy parts, abortion in pregnant ewes, and high mortality. Goat pox is a legally notifiable infectious disease stipulated by the World Organization for Animal Health (OIE), and it is listed as a first-class animal disease in my country.
[0003] The existing vaccines for preventing goat pox are mainly attenuate...